Harmony Biosciences Holdings, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, entered into a new $185 million senior secured term loan facility with a bank...
Read Story
July 31, 2023, 06:00 AM
|
Harmony Biosciences Holdings, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, and Blackstone entered into a strategic financing collaboration where funds managed...
Read Story
August 12, 2021, 07:06 AM
|